ID: ALA3084810

Max Phase: Preclinical

Molecular Formula: C15H25NO2

Molecular Weight: 251.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCNC(=O)OC1C2CC3CC(C2)CC1C3

Standard InChI:  InChI=1S/C15H25NO2/c1-2-3-4-16-15(17)18-14-12-6-10-5-11(8-12)9-13(14)7-10/h10-14H,2-9H2,1H3,(H,16,17)

Standard InChI Key:  JWFLTSVSQOTQSP-UHFFFAOYSA-N

Associated Targets(non-human)

Butyrylcholinesterase 805 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 251.37Molecular Weight (Monoisotopic): 251.1885AlogP: 3.34#Rotatable Bonds: 4
Polar Surface Area: 38.33Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.31CX LogD: 3.31
Aromatic Rings: 0Heavy Atoms: 18QED Weighted: 0.78Np Likeness Score: -0.01

References

1. Lin G, Chen GH, Ho HC..  (1998)  Conformationally restricted carbamate inhibitors of horse serum butyrylcholinesterase.,  (19): [PMID:9873615] [10.1016/s0960-894x(98)00484-3]

Source